NeuroTherapeutics Pharma, Inc. — Form D
NeuroTherapeutics Pharma, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2009-01-06. The offering totals $5.8M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-01-06
- Form: D
- Accession: 0001385386-09-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.8M
- Amount sold: $3.2M
- Remaining: $2.5M
- Minimum investment: $6K
- Investors: 4
- Date of first sale: 2008-12-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-98351
Issuer
- Name: NeuroTherapeutics Pharma, Inc.
- CIK: 0001385386
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 8420 W. BYRN MAWR AVENUE, CHICAGO, IL, 60631
- Phone: (773) 444-4180
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Karen Boezi | Director | Kensington, CA |
| Heath Lukatch, Ph.D. | Director | Redwood City, CA |
| Phillip F Morgan, Ph.D. | Director | Chicago, IL |
| Christine P Siu | Director | Boston, MA |
| THOMAS R BECK, M.D. | Director | CHICAGO, IL |
| RAJEEV R DADOO, Ph.D. | Director | CHICAGO, IL |
| STEPHEN P WANASKI | Executive Officer | CHICAGO, IL |
| JASON A BROWN, PH.D. | Director | CHICAGO, IL |
| BRIAN B WILLIAMS | Executive Officer | CHICAGO, IL |
| TODD P VERDOORN, Ph.D. | Executive Officer | CHICAGO, IL |
| ELAINE V JONES, PH.D. | Director | CHICAGO, IL |
| COREY A GOODMAN, Ph.D. | Director | CHICAGO, IL |
| HEATH R LUKATCH, Ph.D. | Director | CHICAGO, IL |
| STEPHEN D COLLINS, M.D., PH.D. | Director | CHICAGO, IL |
| STEPHEN D COLLINS, M.D., PH.D. | Executive Officer | CHICAGO, IL |
| HOLLI A CARLSON | Executive Officer | CHICAGO, IL |
| MICHAEL P VENUTI, Ph.D | Executive Officer | CHICAGO, IL |
| LUKE A EVNIN, Ph.D. | Director | CHICAGO, IL |
| Stephen P Wanaski, Ph.D. | Executive Officer | Chicago, IL |
| Corey P Goodman, Ph.D. | Director | Chicago, IL |
| Luke P Evnin, Ph.D. | Director | Chicago, IL |
Other filings by this issuer (2)
More